English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  53284890    ???header.onlineuser??? :  922
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"su"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 136-145 of 1207  (121 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page

Institution Date Title Author
國立成功大學 2024-06-1 Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) as first-line (1L) therapy for advanced non-small cell lung cancer (aNSCLC): Subgroup analysis from TROPION-Lung02 Levy;Philip, Benjamin;Paz-Ares;Luis, G.;Su;Wu-Chou;Herbert;Scott, M.;Yang;Tsung-Ying;Tolcher;Anthony, W.;Lou;Yanyan;Zenke;Yoshitaka;Cortinovis;Luigi, Diego;Felip;Enriqueta;Domine;Manuel;Sr;Leventakos;Konstantinos;Calvo;Emiliano;Horiike;Atsushi;Pan;Edward;Lin;Daisy;Jia;Xiaoyu;Basak;Priyanka;Chisamore;Jon, Michael;Goto;Yasushi
國立成功大學 2024-06-1 Intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously treated advanced/metastatic non-small cell lung cancer (a/m NSCLC) with actionable genomic alterations (AGA): Results from TROPION-Lung05 Lisberg;Aaron;Ahn;Myung-Ju;Kitazono;Satoru;Cho;Chul, Byoung;Blumenschein;George, R.;Shum;Elaine;Pons-Tostivint;Elvire;Goto;Yasushi;Yoh;Kiyotaka;Paz-Ares;Luis, G.;Heist;Suk, Rebecca;Baas;Paul;Planchard;David;Perol;Maurice;Felip;Enriqueta;Su;Wu-Chou;Zebger-Gong;Hong;Lan;Lan;Liu;Chelsea;Sands;Jacob
國立成功大學 2024-06-04 Implementation of shared decision-making about rooming-in: A before and after an audit of breastfeeding in Taiwan Hung;Hsiao-Ying;Wen;Chun-Che;Su;Pei-Fang;Man;Shek-Yip;Chang;Ying-Ju
國立成功大學 2024-06-02 PRMT-7/PRMT7 activates HLH-30/TFEB to guard plasma membrane integrity compromised by bacterial pore-forming toxins Hsieh;Hui-Chen;Huang;I-Hsiang;Chang;Shao-Wen;Chen;Po-Lin;Su;Yu-Cheng;Wang;Shuying;Tsai;Wei-Jiun;Chen;Ping-Hung;Aroian;Raffi, V.;Chen;Chang-Shi
國立成功大學 2024-06-01 Efficacy and safety of erdafitinib in patients with advanced or metastatic cholangiocarcinoma and FGFR alterations: Pooled analysis of RAGNAR and LUC2001 studies. Pant;Shubham;Park;Oh, Joon;Su;Wu-Chou;Schuler;Martin, H.;Loriot;Yohann;Iyer;Gopa;Doi;Toshihiko;Qin;Shukui;Tabernero;Josep;Prenen;Hans;Folprecht;Gunnar;Winter;Helen;Molin, Dal;Zibetti, Graziela;Sweiti;Hussein;Najmi;Saltanat;Hammond;Constance;Liao;Huimin;Thomas;Shibu;Triantos;Spyros;Feng;Yin-Hsun
國立成功大學 2024-06 Mechanical, Tribological, and Anti-corrosion Properties of Nitrogen-Doped AlCrNbSiTiMoW High-Entropy Coatings Kao;W, H.;Su;Y, L.;Lin;Y, J.
國立成功大學 2024-06 Experimental and Numerical Study of Suspended Inter-Array Cable Configurations for Floating Offshore Wind Farm Li;Di-Rong;Su;Yu-Shiou;Yang;Ray-Yeng
國立成功大學 2024-06 Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Na�ve Patients from a Nationwide HCV Registry in Taiwan Yang;Chun-Chi;Huang;Chung-Feng;Chang;Te-Sheng;Lo;Ching-Chu;Hung;Chao-Hung;Huang;Chien-Wei;Chong;Lee-Won;Cheng;Pin-Nan;Yeh;Ming-Lun;Peng;Cheng-Yuan;Cheng;Chien-Yu;Huang;Jee-Fu;Bair;Ming-Jong;Lin;Chih-Lang;Yang;Chi-Chieh;Wang;Szu-Jen;Hsieh;Tsai-Yuan;Lee;Tzong-Hsi;Lee;Pei-Lun;Wu;Wen-Chih;Lin;Chih-Lin;Su;Wei-Wen;Yang;Sheng-Shun;Wang;Chia-Chi;Hu;Jui-Ting;Mo;Lein-Ray;Chen;Chun-Ting;Huang;Yi-Hsiang;Chang;Chun-Chao;Huang;Chia-Sheng;Chen;Guei-Ying;Kao;Chien-Neng;Tai;Chi-Ming;Liu;Chun-Jen;Lee;Mei-Hsuan;Kuo;Hsing-Tao;Tsai;Pei-Chien;Dai;Chia-Yen;Kao;Jia-Horng;Lin;Han-Chieh;Chuang;Wang-Long;Tseng;Kuo-Chih;Chen;Chi-Yi;Yu;Ming-Lung
國立成功大學 2024-06 Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation Su;Yung-Yeh;Chiang;Nai-Jung;Chiu;Tai-Jan;Huang;Chien-Jui;Hsu;Shao-Jung;Lin;Hsin-Chen;Yang;Shih-Hung;Yang;Youngsen;Chou;Wen-Chi;Chen;Yen-Yang;Bai;Li-Yuan;Li;Chung-Pin;Chen;Jen-Shi
國立成功大學 2024-06 Real-world effectiveness and safety of 8-week glecaprevir/pibrentasvir for treatment-naive patients from Taiwan nationwide HCV registry Huang;Chung-Feng;Chang;Te-Sheng;Kuo;Hsing-Tao;Huang;Chien-Wei;Mo;Lien-Ray;Tai;Chi-Ming;Tseng;Kuo-Chih;Bair;Ming-Jong;Wang;Sih-Ren;Lo;Ching-Chu;Chong;Lee-Won;Cheng;Pin-Nan;Yeh;Ming-Lun;Peng;Cheng-Yuan;Cheng;Chien-Yu;Huang;Jee-Fu;Lin;Chih-Lang;Yang;Chi-Chieh;Hsieh;Tsai-Yuan;Lee;Tzong-Hsi;Lee;Pei-Lun;Wu;Wen-Chih;Lin;Chih-Lin;Su;Wei-Wen;Yang;Sheng-Shun;Wang;Chia-Chi;Hu;Jui-Ting;Chen;Chun-Ting;Huang;Yi-Hsiang;Chang;Chun-Chao;Huang;Chia-Sheng;Chen;Guei-Ying;Kao;Chien-Neng;Liu;Chun-Jen;Lee;Mei-Hsuan;Tsai;Pei-Chien;Dai;Chia-Yen;Kao;Jia-Horng;Lin;Han-Chieh;Chuang;Wan-Long;Hung;Chao-Hung;Chen;Chi-Yi;Yu;Ming-Lung

Showing items 136-145 of 1207  (121 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page